NEW chemical entities (NCEs) gaining marketing approval by the Therapeutic Goods Administration (TGA) in Australia during 2016 have been listed on the TGA website along with Extensions of Indications registrations approved.
Antizol (fomepizole) from AFT Pharmaceuticals, a treatment for ethylene glycol or methanol poisoning was listed as a new chemical entity in Dec.
Also in Dec, Ferring's Nocdurna (desmopressin) was granted an extended listing to now include its use for the treatment of nocturia under certain conditions.
Visit www.tga.gov.au for the full year's listings.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 16
